Physician profile
Eric Jason Conley
NPI 1639202211
$115,871.10
in general payments reported to CMS, 2019-2025
17 companies · $738 in 2025
The $738 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $47.45 · 2021: $366 · 2022: $66K · 2023: $42K · 2024: $5,812 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Travel and Lodging: $19K · Food and Beverage: $2,147 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,134.21 |
| Travel and Lodging | $18,935.34 |
| Food and Beverage | $2,146.72 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $113,294.53 | 2019-2024 | Kxl System (Not Refurbished), Ce-Marked Kxla System, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Tarsus Pharmaceuticals, INC. | $403.72 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $383.60 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $329.44 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $235.71 | 2019 | |
| Oyster Point Pharma, INC. | $205.73 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $202.41 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $182.67 | 2020-2024 | |
| Allergan, INC. | $149.14 | 2019-2021 | |
| Harrow Eye, LLC | $148.17 | 2024-2025 | Vevye |
| Alcon Vision LLC | $147.10 | 2019-2025 | Simbrinza, Eysuvis |
| Novartis Pharmaceuticals Corporation | $43.04 | 2019 | |
| Ivantis, INC | $42.85 | 2019 | |
| Quidel Corporation | $39.00 | 2019 | |
| Shire North American Group INC | $21.90 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.23 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $20.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.